Does Dr. SRINIVAS DUKKIPATI have financial conflicts of interest?

Dr. SRINIVAS DUKKIPATI (MD) has received a total of $2,680,928 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,680,928 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SRINIVAS DUKKIPATI?

According to CMS Open Payments data, Dr. SRINIVAS DUKKIPATI received funding from BOSTON SCIENTIFIC CORPORATION ($2,673,987), BIOSENSE WEBSTER ($5,234), and ABBOTT LABORATORIES ($881).

Does Dr. SRINIVAS DUKKIPATI receive research grants or speaking fees?

Dr. SRINIVAS DUKKIPATI has received $2,680,928 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SRINIVAS DUKKIPATI

MDReal-Time Hydrated

Specialty: Internal Medicine, Clinical Cardiac Electrophysiology

Practice Location: NEW YORK, NY 10029

NPI Number: 1144259433

LIFETIME INDUSTRY VALUE

$2,680,928

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. DUKKIPATI is a verified Internal Medicine, Clinical Cardiac Electrophysiology practitioner based in NEW YORK, NY.

Between 2021 and 2024, Dr. DUKKIPATI had an overall industry promotional and research financial footprint of $2,680,928 as recorded in the federal CMS Open Payments database.

$2,680,928 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. DUKKIPATI's primary funding source is BOSTON SCIENTIFIC CORPORATION, which accounts for $2,673,987 (representing 99.7% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOSTON SCIENTIFIC CORPORATION

Rank 1

$2,673,987

99.7%

BIOSENSE WEBSTER

Rank 2

$5,234

0.2%

ABBOTT LABORATORIES

Rank 3

$881

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.